As of 2026-06-10, the Relative Valuation of Jafron Biomedical Co Ltd (300529.SZ) is 18.28 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 16.50 CNY, the upside of Jafron Biomedical Co Ltd based on Relative Valuation is 10.8%.
The range of the Relative Valuation is 14.54 - 24.78 CNY.
| Range | Selected | |
| Trailing P/E multiples | 26.3x - 35.1x | 29.1x |
| Forward P/E multiples | 19.6x - 22.7x | 21.5x |
| Fair Price | 14.54 - 24.78 | 18.28 |
| Upside | -11.9% - 50.2% | 10.8% |
| Date | P/E |
| 2026-05-26 | 25.97 |
| 2026-05-25 | 26.27 |
| 2026-05-22 | 26.58 |
| 2026-05-21 | 26.44 |
| 2026-05-20 | 26.71 |
| 2026-05-19 | 27.09 |
| 2026-05-18 | 26.83 |
| 2026-05-15 | 27.20 |
| 2026-05-14 | 27.51 |
| 2026-05-13 | 28.14 |
| 2026-05-12 | 28.19 |
| 2026-05-11 | 28.29 |
| 2026-05-08 | 27.60 |
| 2026-05-07 | 27.09 |
| 2026-05-06 | 27.34 |
| 2026-04-30 | 26.93 |
| 2026-04-29 | 26.96 |
| 2026-04-28 | 27.20 |
| 2026-04-27 | 25.69 |
| 2026-04-24 | 26.28 |
| 2026-04-23 | 26.31 |
| 2026-04-22 | 25.99 |
| 2026-04-21 | 26.45 |
| 2026-04-20 | 24.87 |
| 2026-04-17 | 24.83 |
| 2026-04-16 | 25.07 |
| 2026-04-15 | 25.08 |
| 2026-04-14 | 24.80 |
| 2026-04-13 | 24.70 |
| 2026-04-10 | 24.87 |
| 2026-04-09 | 24.60 |
| 2026-04-08 | 25.24 |
| 2026-04-07 | 24.49 |
| 2026-04-03 | 24.49 |
| 2026-04-02 | 25.18 |
| 2026-04-01 | 25.39 |
| 2026-03-31 | 25.08 |
| 2026-03-30 | 25.19 |
| 2026-03-27 | 25.07 |
| 2026-03-26 | 24.71 |
| 2026-03-25 | 25.07 |
| 2026-03-24 | 25.09 |
| 2026-03-23 | 24.81 |
| 2026-03-20 | 25.82 |
| 2026-03-19 | 26.35 |
| 2026-03-18 | 26.75 |
| 2026-03-17 | 26.98 |
| 2026-03-16 | 26.75 |
| 2026-03-13 | 26.64 |
| 2026-03-12 | 26.67 |